sr31 peptide SS-31 peptide enables mitochondrial targeting drug delivery

sr31 peptide SS-31 Peptide - SS31peptideprotocol SS-31 is a synthetic tetrapeptide

SS-31peptidedose The sr31 peptide, also widely known as SS-31 or elamipretide, is a synthetic tetrapeptide that has garnered significant attention for its remarkable ability to target and accumulate within mitochondria. This unique characteristic allows it to play a crucial role in cellular energy production and protection.作者:P List—Research overview of SS-31 and MOTS-c examiningmitochondrial bioenergetics, metabolic signaling, and aging-related mechanismsin laboratory models. Research indicates that SS-31 acts as a mitochondria-targeting antioxidant, designed to scavenge reactive oxygen species and protect these vital cellular powerhouses from damage.SS-31 is a synthetic tetrapeptidedesigned to target and accumulate within the inner mitochondrial membrane. It binds selectively to cardiolipin. Its therapeutic potential lies in its capacity to improve mitochondrial function, reduce oxidative stress, and ultimately restore cellular energy balance, positioning it as a promising agent for addressing various age-related dysfunctions and diseases.

Understanding the Mechanism of Action

At its core, the sr31 peptide's efficacy stems from its specific interaction with cardiolipin, a phospholipid predominantly found in the inner mitochondrial membrane.Elamipretide This binding is crucial as cardiolipin plays a vital role in maintaining mitochondrial structure, function, and the efficiency of the electron transport chainSS-31 peptide enables mitochondrial targeting drug delivery. By selectively accumulating in mitochondria and binding to cardiolipin, SS-31 helps to stabilize this critical membrane. This stabilization is understood to be key to its protective effects, preventing the leakage of harmful molecules and preserving the integrity of the organelle.

Furthermore, SS-31's ability to target mitochondria allows it to directly influence mitochondrial bioenergetics. It has been shown to enhance the production of adenosine triphosphate (ATP), the primary energy currency of cells, thereby improving cellular energy production. This mechanism is particularly relevant in conditions where mitochondrial dysfunction contributes to disease pathogenesis or the aging process.SS-31 Peptide: A Mitochondrial Targeted Therapeutic ...

Therapeutic Potential and Applications

The research surrounding the sr31 peptide points to a broad spectrum of potential therapeutic applications.SS-31, also known as also known as MTP-131, elamipretide and Bendavia,is a unique tetrapeptide that specifically targets the mitochondria within cells. Its capacity to restore mitochondrial health and function makes it a candidate for treating a range of conditions characterized by cellular energetic deficits and oxidative stress.SS-31

* Age-Related Decline: SS-31 is being investigated for its potential to reverse aspects of age-related mitochondrial dysfunction.作者:P List—Research overview of SS-31 and MOTS-c examiningmitochondrial bioenergetics, metabolic signaling, and aging-related mechanismsin laboratory models. Studies suggest it can improve skeletal muscle energetics, enhance exercise capacity, and combat age-related cellular decline by directly addressing the root causes of mitochondrial aging.

* Organ Protection and Repair: The peptide has demonstrated protective effects in various organs. For instance, it has been studied for its ability to ameliorate kidney damage by reducing mitochondrial oxidative stress and improving cellular function.SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney ... Its role in protecting hair cells from damage, as seen in studies related to aminoglycoside toxicity, also highlights its organ-protective capabilitiesSS-31 10mg.

* Neurodegenerative Diseases: Emerging research suggests SS-31 may offer therapeutic benefits for neurodegenerative conditions. Its ability to attenuate neurodegeneration, particularly concerning alpha-synuclein misfolding and aggregation, points to a potential role in managing diseases like Parkinson's.SS-31 Peptide – High Purity Mitochondrial Peptide (20mg)

* Specific Genetic Disorders: Elamipretide (SS-31) has been developed as a medication for specific conditions, such as Barth syndrome, a rare genetic disorder characterized by severe mitochondrial dysfunctionSS-31 (also known as Bendavia, Elamipretide, and MTP-131)is a small peptide(D-Arg- dimethyl-Tyr-Lys-Phe-NH2) that accumulates in mitochondria and ....

Safety and Usage Considerations

While research into SS-31 is ongoing and promising, it's important to note that its widespread clinical application is still evolving. The peptide is often referred to as pharmaceutical-grade, underscoring its development for medical use. However, detailed information regarding dosage protocols, potential side effects, and long-term safety profiles is typically derived from clinical trials and ongoing research.SS-31 is a synthetic tetrapeptidedesigned to target and accumulate within the inner mitochondrial membrane. It binds selectively to cardiolipin. For individuals considering SS-31, whether for research purposes or potential therapeutic use, consulting with healthcare professionals and staying informed about the latest scientific findings and regulatory approvals is paramount. The peptide's unique mechanism of action, targeting mitochondrial dysfunction at its source, offers a precise approach to cellular repair and energy restoration, making it a significant area of ongoing scientific and medical exploration.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.